Global Gingival Recession market size is expected to reach $4.42 Billion by 2030 at 6%, increasing awareness of oral health fueling the growth of the market due to rising focus on prevention and treatment of dental issues
Read MoreGlobal Giant-Cell Arteritis market size is expected to reach $1.39 billion by 2030 at 4.3%, segmented as by prednisone, oral prednisone, intravenous (iv) prednisone, low-dose prednisone therapy, high-dose prednisone therapy
Read MoreGlobal GI Stool Testing market size is expected to reach $1.99 billion by 2030 at 7.1%, the growing prevalence of gastrointestinal disorders driving the expansion of the market due to rising health concerns and diagnostic needs
Read MoreGlobal Gestational Trophoblastic Disease market size is expected to reach $2.81 billion by 2030 at 5.7%, segmented as by hydatidiform mole, complete hydatidiform mole, partial hydatidiform mole
Read MoreGlobal Gestational Diabetes market size is expected to reach $13.85 billion by 2030 at 8.7%, impact of rising obesity rates on healthcare demand
Read MoreGlobal Germ Cell Tumor market size is expected to reach $22.55 billion by 2030 at 14.4%, segmented as by testicular, seminomas, non-seminomas
Read MoreGlobal Hematopoietic Stem Cell Transplantation market size is expected to reach $8.57 billion by 2030 at 11%, rising blood cancer incidence fuels growth in the hematopoietic stem cell transplantation market
Read MoreThe hematology analyzers market is growing strongly, rising from $5.66 in 2025 to $4.05B in 2026 at 6.8% CAGR. Growth is driven by aging populations, chronic disease rates, and AI-based innovations.
Read MoreGlobal Hematologic Malignancies Testing market size is expected to reach $6.68 by 2030 at 13.2%, increase in cancer diagnoses fueling the growth of the market due to enhanced screening access and early detection
Read MoreThe hematologic malignancies detection market is projected to reach $6.28 billion by 2030, growing at 15.1% CAGR, driven by liquid biopsy, AI diagnostics, and precision oncology testing.
Read More